D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$322M |
| 2 |
AABA
Altaba Inc
AABA
|
+$288M |
| 3 |
TJX Companies
TJX
|
+$254M |
| 4 |
PayPal
PYPL
|
+$210M |
| 5 |
Liberty Media Series C
FWONK
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$374M |
| 2 |
Citigroup
C
|
+$301M |
| 3 |
Netflix
NFLX
|
+$221M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$215M |
| 5 |
Oracle
ORCL
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.75% |
| 2 | Healthcare | 11.67% |
| 3 | Consumer Discretionary | 9.57% |
| 4 | Financials | 9.15% |
| 5 | Industrials | 7.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Autodesk
ADSK
$50.9B
| $3.08M | 0.01% |
30,596
+27,025
| +757% | +$2.67M |
|
|
OTIC
1652
DELISTED
Otonomy, Inc.
OTIC
| $3.08M | 0.01% |
163,587
-2,753
| -2% | -$38.4K |
|
|
BEAT
1653
DELISTED
BioTelemetry, Inc.
BEAT
| $3.07M | 0.01% |
91,909
-36,408
| -28% | -$1.09M |
|
1654
W.P. Carey
WPC
$17.1B
| $3.07M | 0.01% |
47,526
-42,191
| -47% | -$2.67M |
|
|
EXTN
1655
DELISTED
Exterran Corporation
EXTN
| $3.07M | 0.01% |
114,965
+19,545
| +20% | +$554K |
|
1656
NetEase
NTES
$81.9B
| $3.06M | 0.01% |
50,965
-2,248,495
| -98% | -$129M |
|
|
CONN
1657
DELISTED
Conn's Inc.
CONN
| $3.06M | 0.01% |
160,244
+143,406
| +852% | +$2.32M |
|
1658
National Grid
NGG
$82.1B
| $3.05M | 0.01% |
54,956
-284,232
| -84% | -$17.4M |
|
1659
Rithm Capital
RITM
$5.47B
| $3.05M | 0.01% |
+196,200
| New | +$3.25M |
|
1660
Griffon
GFF
$4.32B
| $3.05M | 0.01% |
139,038
+5,161
| +4% | +$119K |
|
1661
Houlihan Lokey
HLI
$10.1B
| $3.05M | 0.01% |
87,379
-116,726
| -57% | -$3.96M |
|
1662
PUT
Valero Energy
VLO
$89.1B
| $3.05M | 0.01% |
45,200
+1,300
| +3% | +$84.3K |
|
1663
PUT
RTX Corp
RTX
$292B
| $3.04M | 0.01% |
+39,566
| New | +$2.96M |
|
|
ESIO
1664
DELISTED
Electro Scientific Industries
ESIO
| $3.04M | 0.01% |
368,984
+25,971
| +8% | +$200K |
|
1665
CALL
Veeva Systems
VEEV
$32.8B
| $3.03M | 0.01% |
+49,400
| New | +$2.85M |
|
1666
CALL
Petrobras
PBR
$117B
| $3.02M | 0.01% |
378,000
-1,288,500
| -77% | -$11.5M |
|
|
GNMK
1667
DELISTED
GenMark Diagnostics, Inc
GNMK
| $3.01M | 0.01% |
254,382
+61,841
| +32% | +$791K |
|
|
HCAC.U
1668
DELISTED
Hennessy Capital Acquisition Corp. III Units, each consisting of one share of Common Stock and one-h
HCAC.U
| $2.99M | ﹤0.01% |
+297,760
| New | +$2.99M |
|
|
GAP
1669
The Gap Inc
GAP
$7.3B
| $2.98M | ﹤0.01% |
135,627
+95,180
| +235% | +$2.26M |
|
|
LXFT
1670
DELISTED
Luxoft Holding, Inc.
LXFT
| $2.98M | ﹤0.01% |
48,970
+27,757
| +131% | +$1.74M |
|
1671
Vishay Precision Group
VPG
$1.17B
| $2.98M | ﹤0.01% |
172,126
-437
| -0.3% | -$7.49K |
|
|
EGL
1672
DELISTED
Engility Holdings, Inc.
EGL
| $2.98M | ﹤0.01% |
104,852
+1,889
| +2% | +$52.7K |
|
1673
Bank of N.T. Butterfield & Son
NTB
$2.38B
| $2.97M | ﹤0.01% |
87,186
+44,234
| +103% | +$1.47M |
|
|
AVDL
1674
DELISTED
Avadel Pharmaceuticals
AVDL
| $2.97M | ﹤0.01% |
269,141
+19,278
| +8% | +$194K |
|
1675
PUT
SM Energy
SM
$7.2B
| $2.96M | ﹤0.01% |
179,300
+145,000
| +423% | +$2.88M |
|
Similar funds
D.E. Shaw & Co's Q2 2017 Portfolio in Review
As of Q2 2017, D.E. Shaw & Co held 3,739 positions worth $60.5B, up 6.3% from $56.9B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
D.E. Shaw & Co's Q2 2017 filing shows 483 new, 1,217 increased, 1,312 reduced and 407 closed positions. Its largest new stake was Altaba Inc: 5,284,075 shares worth $288M. The largest sale was McDonald's, an estimated $374M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- D.E. Shaw & Co's largest Q2 2017 buy was Altaba Inc: 5,284,075 shares worth $288M.
- D.E. Shaw & Co added most to Verizon in Q2 2017, an estimated $322M increase.
- D.E. Shaw & Co's biggest Q2 2017 reduction was McDonald's, cutting an estimated $374M.
- D.E. Shaw & Co fully exited Yahoo Inc in Q2 2017, selling an estimated $215M.
- D.E. Shaw & Co's ten largest holdings make up 9.8% of its $60.5B portfolio in Q2 2017.
- D.E. Shaw & Co opened 483 new positions and closed 407 in Q2 2017.
- D.E. Shaw & Co's portfolio value rose 6.3% quarter-over-quarter to $60.5B.
Based on D.E. Shaw & Co's 13F filing for Q2 2017, filed 14 Aug 2017.